Fig. 4.
Quantitative analysis of the repopulating capacity of CD34+Lin− and CD34+CD38+Lin− cell populations isolated from G-CSF plus SCF–mobilized PB.
Summary of human cell engraftment in NOD/SCID EMVnull mice that received transplants of (A) G-CSF plus SCF–mobilized CD34+Lin− or CD34+CD38+Lin− cells. Cells were injected into the tail vein of sublethally irradiated NOD/SCID EMVnull mice at the dose ranges indicated. Mouse BM cells were extracted 6 to 8 weeks after transplantation to detect the presence of human cells by flow cytometry. Each symbol (▪) represents a single mouse with CD34+Lin− or CD34+CD38+Lin+ transplanted cells derived from a total of 5 independent G-CSF plus SCF–mobilized samples (n = 14). Human engraftment was observed with 100 000 G-CSF plus SCF–mobilized CD34+Lin− and CD34+CD38+Lin− cells. Representative Southern blot analysis of human cell engraftment after transplantation with (B) G-CSF plus SCF–mobilized CD34+Lin− and CD34+CD38−Lin− cells. The level of human engraftment was determined by comparing the characteristic 2.7-kb band to human-to-mouse DNA mixture controls.